Primary prevention of pulmonary heart disease
Behnke, R.H.; Blount, S.G.; Bristow, J.D.; Carrieri, V.; Pierce, J.A.; Sasahara, A.; Soffer, A.; Greenspan, R.
Journal of the American Osteopathic Association 69(11): 1139-1146
1970
ISSN/ISBN: 0098-6151 PMID: 5202395 Document Number: 26471
Document emailed within 1 workday
Related Documents
Kis, A. 1975: Primary prevention of ischemic heart disease Terapevticheskii Arkhiv 47(5): 95-107Pribylov, S.A. 2006: Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease Kardiologiia 46(9): 36-40
Stamler, J. 1973: Heart disease prevention in industry. Primary prevention in mass community efforts to control the major coronary risk factors: the challenges and possibilities--critical issues and outlook for the future Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 15(1): 54-59
Ushakov, G.N.; Gasilin, V.S.; Konovalov, S.V.; Melent'ev, A.S.; Kruglov, V.A.; Rostokin, I.A.; Akhromeev, A.V. 1989: Effectiveness of primary multifactorial prevention of ischemic heart disease Sovetskoe Zdravookhranenie 1989(9): 34-37
Környei, V. 1983: Primary prevention of ischemic heart disease. Possible and indicated management in childhood Orvosi Hetilap 124(7): 371-377
Kannel, W.B. 1990: Implications of the primary prevention trials against coronary heart disease Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 8(7): S245-S250
Ianushkevichus, Z.I.; Baubinene, A.V. 1980: Pressing problems of the primary prevention of ischemic heart disease Kardiologiia 20(1): 11-13
Gliksman, M.D.; Dwyer, T.; Boulton, T.J. 1987: Should the primary prevention of coronary heart disease commence in childhood? Medical Journal of Australia 146(7): 360-362
Meinertz, T.; Heitzer, T. 2002: Primary and secondary prevention of coronary heart disease: smoking Zeitschrift für Kardiologie 91 Suppl. 2: 3-11
Wicklmayr, M.; Rett, K.; Standl, E. 1994: How can primary prevention of coronary heart disease be improved in general practice? Medizinische Klinik 89(4): 184-6 229
Wilhelmsen, L. 1977: Primary and secondary risk factors for coronary heart disease: their role in prevention Medical Journal of Malaysia 31(4): 296-301
Carneiro, Aónio.Vaz.; Costa, Jão.; Borges, M. 2004: Statins for primary and secondary prevention of coronary heart disease. A scientific review Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 23(1): 95-122
Gryglik, J. 1979: Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease Polski Tygodnik Lekarski 34(13): 509-511
Grundy, S.M. 1992: Primary prevention of coronary heart disease with drug therapy. Safety and total mortality issues Archives of Internal Medicine 152(7): 1369-1371
Kocemba, J.; Kawecka-Jaszcz, K.; Magdoń, M. 1981: The effect of six years lasting primary non pharmacological prevention of coronary heart disease on hypercholesterolemia in occupationally working men Przeglad Lekarski 38(12): 857-860
Dokuchaeva, E.A.; Metelitsa, V.I. 1977: Socio-hygiene examination of male middle-aged population in connection with primary prevention of ischemic heart disease Kardiologiia 17(6): 92-96
Martens, L.L.; Guibert, R. 1994: Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease Clinical Therapeutics 16(6): 1052-62; discussion 1036
Shoĭkhet, I.N.; Klester, E.B.; Golovin, V.A. 2008: Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease Klinicheskaia Meditsina 86(3): 21-26
Irlam, J.; Mayosi, B.M.; Gaziano, T.A. 2008: Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option Indian Journal of Pediatrics 75(1): 86; Author Reply 86-7
1980: W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators Lancet 2(8191): 379-385